Also known as: UKRI
The UK's £1.6bn national AI strategy targets healthcare breakthroughs from cancer detection to drug discovery. The AI healthcare market is forecast to reach US$696bn by 2034, a 38.5% CAGR.
UK Research and Innovation has announced major changes to grant funding, with pauses and cuts affecting medical, biological and physical research. The uncertainty has raised concern over curiosity-driven research, staffing and the system’s tolerance for failure.
Research communities in the US and UK face funding disruptions as governments demand greater alignment with national priorities. UKRI has paused grant programs while early-career researchers advocate for increased NIH funding.
